44.25
前日終値:
$43.58
開ける:
$43.97
24時間の取引高:
20.63M
Relative Volume:
1.00
時価総額:
$65.77B
収益:
$20.62B
当期純損益:
$3.56B
株価収益率:
18.56
EPS:
2.3847
ネットキャッシュフロー:
$3.48B
1週間 パフォーマンス:
+0.50%
1か月 パフォーマンス:
-0.47%
6か月 パフォーマンス:
-52.17%
1年 パフォーマンス:
-58.34%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
44.25 | 64.78B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
103.06 | 175.49B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.25 | 122.28B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.21 | 104.98B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
EW
Edwards Lifesciences Corp
|
82.63 | 48.26B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-30 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific (BSX) Faces FDA Advisory Over Transcarotid Sys - GuruFocus
Boston Scientific (BSX) Faces Potential Device Risk Notification - GuruFocus
Boston Scientific Corp (BSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boston Scientific Corp (BSX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - GlobeNewswire Inc.
BSX|Boston Scientific Corp|Price:43.770|Chg%:+0.190 - TradingKey
BSX|Boston Scientific Corp|Price:44.265|Chg%:+0.685 - TradingKey
Boston Scientific stock trades firm as cardiovascular revenue grows and TAVR momentum supports earni - AD HOC NEWS
Daily Brief Health Care: Boston Scientific, Mitesco Inc, Samsung Biologics and more - Smartkarma
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corp (BSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific stock trades steady as recent earnings and cardiovascular portfolio shape investor - AD HOC NEWS
Boston Scientific Settles With Stryker In Spine Device IP Fight - Law360
Goldman Sachs Launches $510 Million Autocallable Notes Linked to Boston Scientific Stock Performance - Kalkine Media
Boston Scientific Corporation (BSX) Stock forecasts - Yahoo Finance UK
Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Boston Scientific, Stryker Settle Surgical Device Patent Dispute - Bloomberg Law News
Boston Scientific (BSX) Stock Still Looks Undervalued Following Its 58% Slump - Yahoo Finance
Boston Scientific stock trades steadily as device maker grows revenue and prepares for next earnings - Ad-hoc-news.de
Boston Scientific (BSX) Recalls Put Focus On Whether The Stock Still Looks Undervalued - Yahoo Finance
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock? - Yahoo Finance
Boston Scientific stock advances on strong sales and margin gains - Ad-hoc-news.de
Boston Scientific to Combine Light Manufacturing, Global Distribution in Indiana Expansion - Assembly Magazine
Boston Scientific stock holds gains as cardiovascular revenue grows and new devices support long ter - Ad-hoc-news.de
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Boston Scientific stock trades steady as latest earnings highlight growth and margin focus - ad-hoc-news.de
The Bull Case For Boston Scientific (BSX) Could Change Following Global Recall Of CRE Endoscopy Devices - simplywall.st
Boston Scientific stock trades steady as cardiovascular and neuromodulation growth supports earnings - ad-hoc-news.de
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific stock trades steadily as Q1 2026 growth and cardiology portfolio underpin valuatio - Ad Hoc News
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Boston Scientific Expands Medical Device R&D in Ireland With €75 Million Investment - Assembly Magazine
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 42.24 USD - Investing.com
Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside - Yahoo Finance
Why Is Boston Scientific (NYSE:BSX) Growing Medical Technology? - Kalkine Media
Boston Scientific Corp (BSX) Shares Fall 4.5% -- What GF Score o - GuruFocus
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific Slides as WATCHMAN Slowdown Concerns and Fresh Target Cuts Weigh on Shares - Quiver Quantitative
Boston Scientific stock reflects steady medtech demand - ad-hoc-news.de
Boston Scientific stock reflects steady growth outlook as medical device demand expands - ad-hoc-news.de
Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw - Yahoo Finance
Daily Brief Health Care: Pharmaron, Ziyond Pharmaceutical, Boston Scientific and more - Smartkarma
Daily Brief United States: Netflix Inc, Autozone Inc, Boston Scientific, Ecolab Inc, Enterprise Products Partners, Global X Uranium ETF, Gold, Harley Davidson, Lennar Corp A, Mohawk Industries and more - Smartkarma
Boston Scientific Top Brass Sued Over Pacemaker Recall - Law360
BN stock holds steady as Boston Scientific grows its medtech base - ad-hoc-news.de
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):